Calendar Purple Biotech Ltd

Equities

PPBT

IL0007650166

Market Closed - TEL AVIV STOCK EXCHANGE 13:49:49 12/05/2024 BST 5-day change 1st Jan Change
19.4 ILa -2.51% Intraday chart for Purple Biotech Ltd -3.96% -39.18%

Chart calendar Purple Biotech Ltd

910e951.Bg70UmNO0FwzPLamuRaN8BCgF5vi6pwMbx489kiJLqc.MnqjFBMElWticuDeyFTjxiaRWfLRvqtWPkp7sx7fGNNjUY4bMH6pBlBPjg~da875c26bc4caab51ba67282bd828e98

Upcoming events on Purple Biotech Ltd

01/06/2024 19:30 American Society of Clinical Oncology Annual Meeting - Abstract Number: LBA4143
31/07/2024 Q2 2024 Earnings Release (Projected)
04/11/2024 Q3 2024 Earnings Release (Projected)
04/02/2025 Q4 2024 Earnings Release (Projected)

Past events on Purple Biotech Ltd

08/05/2024 Q1 2024 Earnings Release (Projected)
09/04/2024 17:00 American Association for Cancer Research Meeting - Abstract Number 5181
08/04/2024 17:00 American Association for Cancer Research Meeting - Abstract Number 1939
05/03/2024 12:55 Q4 2023 Earnings Release
21/11/2023 11:50 Q3 2023 Earnings Release
28/09/2023 21:40 American Association for Cancer Research Special Conference
22/08/2023 14:29 Q2 2023 Earnings Release
16/05/2023 21:00 Q1 2023 Earnings Release
20/04/2023 19:00 Canaccord Genuity Horizons in Oncology Virtual Conference - Panel
04/06/2021 13:30 Jefferies Healthcare Conference
03/06/2021 American Society of Clinical Oncology Conference
10/04/2021 06:30 American Association for Cancer Research Conference
02/03/2021 12:00 FY 2020 Earnings Release
20/01/2021 15:30 B. Riley Oncology Investor Conference
05/01/2021 LifeSci Advisors Corporate Access Event
16/11/2020 Jefferies Healthcare Conference
12/11/2020 14:00 H.C. Wainwright Israel Conference
11/08/2020 12:15 Interim 2020 Earnings Release
21/06/2020 American Association for Cancer Research Virtual Meeting
29/05/2020 13:00 American Society of Clinical Oncology Virtual Annual Meeting - Abstract No 3094

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00


1,00
4,70
-78.72%
0,00


0,00
0,00
-
0,00
0,00
-

0,00

EBITDA
Released
Forecast
Spread
0,00


0,00
0,00
-
0,00


0,00
0,00
-
0,00
0,00
-

0,00

EBIT
Million USD
Released
Forecast
Spread
0,00


-12,6
-5,81
-117.15%
0,00


-22,6
-21,7
-4.16%
-22,3
-21,2
-5.05%

-18,0

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
0,00


0,00
0,00
-
-17,8


0,00
0,00
-
0,00
-20,0
-

-13,0

Net income
Million USD
Released
Forecast
Spread
-5,85


-28,0
0,00
-
-18,4


0,00
0,00
-
0,00
-20,0
-

-13,0

EPS
USD
Released
Forecast
Spread
-0,30


0,00
0,00
-
0,00


0,00
0,00
-
0,00
0,00
-

0,00

Announcement Date11/02/2002/03/2109/02/2208/02/2305/03/24-

Quarterly results

Fiscal PeriodDecember 2022 S1 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD
Released
Forecast
Spread



0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00


0,00


0,00


0,00

EBIT
Million USD
Released
Forecast
Spread



-5,08
-4,00
-27.03%
-6,60
-5,70
-15.81%
-5,12
-6,90
25.77%
-5,14
-5,00
-2.7%
-5,75
-4,70
-22.28%
-6,27
-5,20
-20.52%

-5,20


-4,70


-4,30


-3,90

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread



















-5,00













Net income
Million USD
Released
Forecast
Spread
-10,8


















-5,00













EPS
USD
Released
Forecast
Spread
-0,06
































Announcement Date04/08/2208/11/2208/02/2316/05/2322/08/2321/11/2305/03/24----

Net sales - Quarter - Rate of surprise

Net sales - Annual - Rate of surprise

  1. Stock Market
  2. Equities
  3. PPBT Stock
  4. Calendar Purple Biotech Ltd